Cyclo killer

Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein

Jeff Chen, Michael Hutchens, Wayne T. Nicholson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Addition of carvedilol (a P-glycoprotein inhibitor) to the cyclosporine (a P-glycoprotein substrate) resulted in increased cyclosporine levels and cyclosporine toxicity.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages641-644
Number of pages4
ISBN (Electronic)9781461474951
ISBN (Print)9781461474944
DOIs
StatePublished - Sep 15 2015

Fingerprint

P-Glycoprotein
Cyclosporine
carvedilol

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chen, J., Hutchens, M., & Nicholson, W. T. (2015). Cyclo killer: Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 641-644). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_142

Cyclo killer : Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein. / Chen, Jeff; Hutchens, Michael; Nicholson, Wayne T.

A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, 2015. p. 641-644.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chen, J, Hutchens, M & Nicholson, WT 2015, Cyclo killer: Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein. in A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, pp. 641-644. https://doi.org/10.1007/978-1-4614-7495-1_142
Chen J, Hutchens M, Nicholson WT. Cyclo killer: Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein. In A Case Approach to Perioperative Drug-Drug Interactions. Springer New York. 2015. p. 641-644 https://doi.org/10.1007/978-1-4614-7495-1_142
Chen, Jeff ; Hutchens, Michael ; Nicholson, Wayne T. / Cyclo killer : Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein. A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, 2015. pp. 641-644
@inbook{70db375a16fa4152b92776ba475a904c,
title = "Cyclo killer: Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein",
abstract = "Addition of carvedilol (a P-glycoprotein inhibitor) to the cyclosporine (a P-glycoprotein substrate) resulted in increased cyclosporine levels and cyclosporine toxicity.",
author = "Jeff Chen and Michael Hutchens and Nicholson, {Wayne T.}",
year = "2015",
month = "9",
day = "15",
doi = "10.1007/978-1-4614-7495-1_142",
language = "English (US)",
isbn = "9781461474944",
pages = "641--644",
booktitle = "A Case Approach to Perioperative Drug-Drug Interactions",
publisher = "Springer New York",

}

TY - CHAP

T1 - Cyclo killer

T2 - Qu'est-ce que c'est?: Carvedilol, cyclosporine, P-glycoprotein

AU - Chen, Jeff

AU - Hutchens, Michael

AU - Nicholson, Wayne T.

PY - 2015/9/15

Y1 - 2015/9/15

N2 - Addition of carvedilol (a P-glycoprotein inhibitor) to the cyclosporine (a P-glycoprotein substrate) resulted in increased cyclosporine levels and cyclosporine toxicity.

AB - Addition of carvedilol (a P-glycoprotein inhibitor) to the cyclosporine (a P-glycoprotein substrate) resulted in increased cyclosporine levels and cyclosporine toxicity.

UR - http://www.scopus.com/inward/record.url?scp=84955409321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955409321&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7495-1_142

DO - 10.1007/978-1-4614-7495-1_142

M3 - Chapter

SN - 9781461474944

SP - 641

EP - 644

BT - A Case Approach to Perioperative Drug-Drug Interactions

PB - Springer New York

ER -